(EURX)

All Comments on EURX

  • commenter
    Ames
    Tiedeman
    Apr 24 06:47 AM
    My Website
    Five Biotech Stocks to Weather a Down Market [view article]
    DNDN has all the risk, but all the reward too. I think the FDA says yes this time. At least for the very latest stage of the prostate menace. Reply
  • commenter
    Portfolio
    Manager
    Apr 15 04:25 PM
    Biotech Stocks: Sector Outlook and Top Picks [view article]
    ZymoGenetics is certainly undervalued right now. The total market cap is less than the value of their approved drug, Recothrom, much less their pipeline. Their team has now developed seven approved drugs. If you think about the total number of new drugs approved in a given year, seven drugs is a pretty impressive number.

    BioMarin is also an excellent company, but as far as I can tell it is not quite as grossly undervalued as ZymoGenetics.     Reply
  • commenter
    SeekingAlpha
    Editors
    Apr 06 05:22 AM
    My Website
    General Discussion on EURX
    Is this a buy or a sell? Reply
Loading...
Symbols:
Authors:
Quick Links: